EAP Supports Call from Canadian Paediatric Society to Prioritize Children’s Needs in Gaza

March 6, 2024

Brussels, 6 March 2024

 

The European Academy of Paediatrics supports the call of the Canadian Paediatric Society to prioritize the needs of children in Gaza (see below). We appeal to all stakeholders to protect in particular children, their needs, health, safety and well-being. We expressly support the demand that all hostages be safely returned along with an immediate and sustained ceasefire.

As paediatricians and allied children’s health care providers, we mourn the ongoing devastation and loss of life and security in Gaza, where thousands have died and approximately 1 million children are internally displaced and face imminent starvation and an uncertain future.

 

We stand with the WHOUNICEFMédecins sans Frontières in calling for an immediate and sustained ceasefire and for the safe return of all remaining hostages taken in the horrific attack of October 7, 2023.

 

As advocates for the well-being of children and youth, we call on all stakeholders and policymakers to uphold these principles in making decisions concerning the ongoing situation in the Middle East:

 

Children deserve special consideration in times of war and conflict.

 

Children in Gaza, like children everywhere, deserve a future free from violence, pain, and trauma. We must use our privilege and voice to advocate for their healthcare, education, and access to the necessities of life including shelter, clean water, and nutritious food.

 

Humanitarian aid – including clean water, shelter, food, and medical supplies– is urgently needed.

 

All parties must allow the free passage and delivery of aid into Gaza and facilitate its delivery to children and families in need.

 

Canada must do everything in its power to facilitate the evacuation and safe passage of children identified through its special temporary resident pathway.

 

In the six weeks since it was announced, no children have been successfully evacuated under Canada’s special pathway. We call on our politicians to work tirelessly to remove these children from harm’s way and assist their entry into Canadian life by ensuring they receive the health care, shelter, education, and psychosocial supports needed upon arrival.

 

Children’s needs must be prioritized in rebuilding efforts.

 

Communities must be cleared of undetonated explosives before families return. Plans for rebuilding and restoration must prioritize the infrastructure children need to thrive: safe family housing, schools, and healthcare facilities.

 

Furthermore, the CPS extends its support and gratitude to the health care professionals who have cared for patients in Gaza under near impossible circumstances. Remaining health care facilities and supplies should be protected from the impacts of further conflict.

Your Enquiries Are Welcome

We will respond to you by Email

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative: